Director at Bowhead Specialty (NYSE: BOW) granted 3,361 restricted units

Rhea-AI Filing Summary

Bowhead Specialty Holdings Inc. director David Clifford Holman received a grant of 3,361 shares of Common Stock in the form of restricted stock units on April 30, 2026. The award was recorded at a price of $0.00 per share as a stock-based compensation grant, not an open-market purchase.

Following this grant, Holman directly owns 5,716 shares of Bowhead Specialty Holdings Inc. common stock. The filing characterizes the transaction as a non-derivative acquisition through a grant or award, and a footnote clarifies that the reported amount reflects restricted stock units.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Holman David Clifford

Role null

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	3,361	$0.00	--

Holdings After Transaction: Common Stock — 5,716 shares (Direct, null)

Footnotes (1)

1. [object Object]

Key Figures

RSU grant size: 3,361 shares Grant price per share: $0.00 per share Post-transaction holdings: 5,716 shares +1 more

4 metrics

RSU grant size 3,361 shares Restricted stock units granted on April 30, 2026

Grant price per share $0.00 per share Recorded value for RSU grant

Post-transaction holdings 5,716 shares Common Stock directly owned after grant

Transaction code A Grant, award, or other acquisition of non-derivative security

Key Terms

restricted stock units, Common Stock, non-derivative, Form 4, +1 more

5 terms

restricted stock units financial

"Reflects restricted stock units."

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

Common Stock financial

"security_title": "Common Stock""

Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.

non-derivative financial

"transaction_type": "non-derivative""

Form 4 regulatory

"INSIDER FILING DATA (Form 4):"

Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.

Grant, award, or other acquisition financial

"transaction_code_description": "Grant, award, or other acquisition""

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Holman David Clifford

(Last) (First) (Middle)

C/O BOWHEAD SPECIALTY HOLDINGS INC.

452 FIFTH AVENUE

(Street)

NEW YORK NEW YORK 10018

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Bowhead Specialty Holdings Inc. [ BOW ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
04/30/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	04/30/2026		A		3,361(1)	A	$0	5,716	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Reflects restricted stock units.

Remarks:

	/s/ H. Matthew Crusey, as attorney-in-fact	05/04/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transaction did Bowhead Specialty Holdings (BOW) report?

Bowhead Specialty Holdings reported that director David Clifford Holman received 3,361 shares of Common Stock as a grant of restricted stock units. The transaction is recorded at $0.00 per share, indicating a compensation award rather than an open-market purchase.

How many Bowhead Specialty (BOW) shares does the director hold after this Form 4?

After the reported grant, director David Clifford Holman directly holds 5,716 shares of Bowhead Specialty Holdings Common Stock. This total includes the 3,361 shares received as restricted stock units, as disclosed in the Form 4 filing and accompanying footnote.

Was the Bowhead Specialty (BOW) Form 4 transaction a stock purchase or a grant?

The transaction was a stock grant, not a market purchase. The Form 4 classifies it under code A as a grant or award acquisition, with 3,361 restricted stock units credited at $0.00 per share to director David Clifford Holman.

What type of security was granted in the Bowhead Specialty (BOW) Form 4?

The Form 4 shows a grant of Common Stock in the form of restricted stock units. A footnote explicitly states that the 3,361 reported shares reflect restricted stock units rather than immediately unrestricted common shares held by the director.

Does the Bowhead Specialty (BOW) director’s Form 4 involve any derivative securities?

No derivative securities are reported in this Form 4. The transaction involves only non-derivative Common Stock in the form of restricted stock units, and the derivative securities summary section in the data is empty.